EDGAR Filing Documents for 0001628280-22-024904

Form 424B5 - Prospectus [Rule 424(b)(5)]:

SEC Accession No. 0001628280-22-024904

Filing Date

2022-09-14

Accepted

2022-09-14 16:12:29

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	424B5	pointbiopharma-424b5final9.htm	424B5	485815
2		logo.jpg	GRAPHIC	59499
3		point-logoxcolour.jpg	GRAPHIC	17537
	Complete submission text file	0001628280-22-024904.txt		593045

Mailing Address 4850 WEST 78TH STREET INDIANAPOLIS IN 46268

Business Address 4850 WEST 78TH STREET INDIANAPOLIS IN 46268 (317) 543-9957

POINT Biopharma Global Inc. (Filer) CIK: 0001811764 (see all company filings)

IRS No.: 850800493 | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-265981 | Film No.: 221243126
SIC: 2834 Pharmaceutical Preparations